MINI FUTURE SHORT - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Borsa Italiana 16:38:48 23/05/2024 BST | ||
| 10.2 EUR | +5.70% |
|
| Current month | +1.79% | ||
| 1 month | +19.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 10.2 | +5.70% |
| 22/05/24 | 9.65 | -2.23% |
| 21/05/24 | 9.87 | +16.25% |
| 20/05/24 | 8.49 | +4.69% |
| 17/05/24 | 8.11 | -7.21% |
Real-time Borsa Italiana
Last update May 23, 2024 at 04:38 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1PXD5 | |
| ISIN | NLBNPIT1PXD5 |
| Date issued | 16/05/2023 |
| Strike | 5,854 € |
| Maturity | 21/12/2035 (4229 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.01 € |
|---|---|
| Lowest since issue | 5.89 € |
| Spread | 0.08 € |
| Spread % | 0.81% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
49.16
EUR
Average target price
52.24
EUR
Spread / Average Target
+6.27%
- Stock Market
- Certificates
- P1PXD5 Certificat
